Metraipolis › archive › dc_78e950ff4f1c

MiR-4664-3p as a potential diagnostic, prognostic, and immunotherapeutic biomarker in NSCLC: modulation of tumor progression through CD8 + T cell regulation — Europe PMC PMID:41262895

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41262895
DOI
10.3389/fonc.2025.1642999
License (as archived)
solo-consultazione
Archived
2026-11-08T19:35:28.162Z
SHA-256 of the archived text
f3ae2cf02639719ab8aa06c12a76a99d00cbaae432fd6efc9ca43c41abdd29e5
Stable URL of this page
https://metraipolis.com/documento/dc_78e950ff4f1c

How to cite

MiR-4664-3p as a potential diagnostic, prognostic, and immunotherapeutic biomarker in NSCLC: modulation of tumor progression through CD8 + T cell regulation — Europe PMC PMID:41262895 — Europe PMC (en), https://europepmc.org/article/MED/41262895 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_78e950ff4f1c (Metraipolis archive dc_78e950ff4f1c, sha256 f3ae2cf02639719ab8aa06c12a76a99d00cbaae432fd6efc9ca43c41abdd29e5)
BibTeX
@misc{dc78e950ff4f1c,
  title = {MiR-4664-3p as a potential diagnostic, prognostic, and immunotherapeutic biomarker in NSCLC: modulation of tumor progression through CD8 + T cell regulation — Europe PMC PMID:41262895},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41262895},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_78e950ff4f1c; sha256 f3ae2cf02639719ab8aa06c12a76a99d00cbaae432fd6efc9ca43c41abdd29e5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41262895. Agents can read the archived copy with the MCP tool read_document.